Contemporary Pediatrics, Digital Edition, May 2011

Article

Searching for Celiac Disease : Who to test and how to test Concussion in the young athlete : Diagnosis, management and prevention Rejuvenate your practice : Change your attitude and bring joy to your work Dermcase : Fat lip in adolescent boy Puzzler : Ten-year-old-girl with worsening cough Updates : AAP policy statements, Asthma protection, Obesity risks, Juvenile Idiopathic Arthritis, Autism, SSTI's

Recent Videos
Paul Kruszka, MD
Herbert Bravo, MD
Tina Tan, MD
Paul Kruszka, MD, MPH, FACMG
Stephanie Anne Deutsch, MD, MS, MSCR, FAAP
H. Westley Phillips, MD
David Turkewitz, MD
H. Westley Phillips, MD
David Turkewitz, MD
Related Content
Asthma associated with memory, executive function difficulty in childrenLatest revision | Image Credit: © Pixel-Shot - © Pixel-Shot - stock.adobe.com.

Asthma associated with memory, executive function difficulty in children

Joshua Fitch, Senior Editor
December 6th 2024
Article

Results demonstrated that those with earlier asthma onset had slower development of episodic memory.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
Image credit: Production Perig

COVID-19 Therapy Roundtable: Defining the Virus Today and Treatment Options

Joshua Fitch, Senior Editor ;John Parkinson
December 5th 2024
Article

In our latest roundtable series, we cover different therapies around COVID-19 treatment and prevention.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
FDA grants Rare Pediatric Disease to 101-PGC-005 for systemic juvenile idiopathic arthritis | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.

FDA grants Rare Pediatric Disease to 101-PGC-005 for systemic juvenile idiopathic arthritis

Joshua Fitch, Senior Editor
December 4th 2024
Article

101-PGC-005 is Type IA prodrug of dexamethasone that targets CD206+ macrophages.

Upadacitinib effective in treating atopic dermatitis through 76 weeksLatest revision | Image Credit: © Rochu_2008 - © Rochu_2008 - stock.adobe.com.

Upadacitinib effective in treating atopic dermatitis through 76 weeks

Joshua Fitch, Senior Editor
December 3rd 2024
Article

In the study through 76 weeks, no new risks were observed with once-daily upadacitinib (15 mg or 30 mg).

© 2024 MJH Life Sciences

All rights reserved.